We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
101.06%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.1M |
| 2 |
Amgen
AMGN
|
+$40.3M |
| 3 |
AbbVie
ABBV
|
+$32.9M |
| 4 |
ExxonMobil
XOM
|
+$26.5M |
| 5 |
Biogen
BIIB
|
+$26.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.46% |
| 2 | Technology | 11.46% |
| 3 | Financials | 10.21% |
| 4 | Energy | 9.8% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Marriott International
MAR
$98.7B
| $341K | 0.02% |
+8,451
| New | +$353K |
|
877
United Bankshares
UBSI
$6.55B
| $341K | 0.02% |
+12,883
| New | +$332K |
|
878
Principal Financial Group
PFG
$23.6B
| $340K | 0.02% |
+9,069
| New | +$332K |
|
|
ESND
879
DELISTED
Essendant Inc.
ESND
| $340K | 0.02% |
+10,136
| New | +$350K |
|
|
IPXL
880
DELISTED
Impax Laboratories, Inc.
IPXL
| $340K | 0.02% |
+17,034
| New | +$302K |
|
|
HNT
881
DELISTED
HEALTH NET INC
HNT
| $340K | 0.02% |
+10,683
| New | +$322K |
|
882
Cabot Corp
CBT
$4.65B
| $339K | 0.02% |
+9,052
| New | +$336K |
|
883
Mueller Industries
MLI
$14.1B
| $339K | 0.02% |
+53,840
| New | +$349K |
|
884
Motorola Solutions
MSI
$69.4B
| $339K | 0.02% |
+5,874
| New | +$344K |
|
885
Chemed
CHE
$6.78B
| $338K | 0.02% |
+4,672
| New | +$343K |
|
|
PVTB
886
DELISTED
PrivateBancorp Inc
PVTB
| $338K | 0.02% |
+15,951
| New | +$308K |
|
887
F5
FFIV
$22.1B
| $336K | 0.02% |
+4,886
| New | +$376K |
|
|
LNCE
888
DELISTED
Snyders-Lance, Inc.
LNCE
| $336K | 0.02% |
+11,822
| New | +$309K |
|
889
Cheniere Energy
LNG
$56.5B
| $335K | 0.02% |
+12,078
| New | +$339K |
|
890
Regal Rexnord
RRX
$14.2B
| $335K | 0.02% |
+5,162
| New | +$361K |
|
891
Huntington Bancshares
HBAN
$35.1B
| $334K | 0.02% |
+42,357
| New | +$316K |
|
892
RLJ Lodging Trust
RLJ
$1.87B
| $334K | 0.02% |
+14,867
| New | +$341K |
|
893
Worthington Enterprises
WOR
$2.76B
| $334K | 0.02% |
+17,063
| New | +$345K |
|
|
ESL
894
DELISTED
Esterline Technologies
ESL
| $334K | 0.02% |
+4,623
| New | +$343K |
|
895
Fidelity National Information Services
FIS
$21.5B
| $333K | 0.02% |
+7,765
| New | +$332K |
|
|
HSNI
896
DELISTED
HSN, Inc.
HSNI
| $333K | 0.02% |
+6,194
| New | +$337K |
|
|
LTM
897
DELISTED
LIFE TIME FITNESS INC
LTM
| $333K | 0.02% |
+6,646
| New | +$316K |
|
|
MWW
898
DELISTED
Monster Worldwide Inc
MWW
| $333K | 0.02% |
+67,783
| New | +$333K |
|
|
CEB
899
DELISTED
CEB Inc.
CEB
| $332K | 0.02% |
+5,246
| New | +$309K |
|
900
Clorox
CLX
$11.6B
| $331K | 0.02% |
+3,979
| New | +$342K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Profund Advisors, which disclosed 1,386 positions worth $1.42B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Gilead Sciences: 789,103 shares worth $40.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Technology and Financials.
- Profund Advisors's largest Q2 2013 buy was Gilead Sciences: 789,103 shares worth $40.4M.
- Profund Advisors's ten largest holdings make up 19% of its $1.42B portfolio in Q2 2013.
- Profund Advisors disclosed 1,386 positions in Q2 2013, its first 13F filing on record.
Based on Profund Advisors's 13F filing for Q2 2013, filed 25 Jul 2013.